0 ratings
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition
genuine image
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition
Bortezomib is a promising anticancer drug targeting the proteasome.
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition
Item #: 19018753

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition

Item #: 19018753

ETB 18160

Price Details

Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )

*All items will import from US

0 ratings Write a review
In stock
us Imported from USA store

QTY:

Order now and get it around Thursday, July 16
Secured transactionsecured transaction

Ubuy works hard to protect your security and privacy. Our advanced payment security system ensures confidentiality by encrypting your information during transmission using AES (Advanced Encryption Standards) and SSL (Secure Socket Layer) protocols. Your payment details are 100% secure as we do not share your payment details with third party sellers.

Our Top Logistics Partners
  • fedex
  • dhl
Bortezomib is a promising anticancer drug targeting the proteasome.
U-Care Warranty:
None
Select a Plan
fast shipping

Fast
Shipping

free return

Free
Return*

secure packaging

Secure Packaging

100% original products

100% Original Products

pci-dss

PCI DSS Compliance

iso certified

ISO 27001 Certified

paypal payment
visa payment
mastercard payment
Note: Step Down Voltage Transformer required for using electronics products of US store (110-120). Recommended power converters Buy Now.

What Stands Out

Comprehensive Overview
This edition provides an extensive examination of Bortezomib, detailing its development, mechanism, and therapeutic impact on multiple myeloma, making it an essential resource for healthcare professionals and researchers.
Evidence-Based Insights
Incorporates cutting-edge research and clinical trials, offering evidence-based insights that enhance understanding of Bortezomib’s efficacy and its role in treatment regimens, supporting informed decision-making in patient care.
Updated Protocols
Includes the latest treatment protocols and guidelines for using Bortezomib, ensuring that practitioners have current, best-practice information for integrating this drug into modern multiple myeloma therapy.

Product Details

Discover Bortezomib, a breakthrough drug for Multiple Myeloma treatment. Order now from Ubuy Ethiopia and avail global delivery. Shop now!
  • Bortezomib is a promising anticancer drug targeting the proteasome
  • Induces cell stress and apoptosis in cancer cells
  • Valuable source of information for researchers and clinicians in oncology and pharmacology
  • Useful for those working in academia or the pharmaceutical industry
  • Focuses on the treatment of Multiple Myeloma (MM) using bortezomib
  • Offers insights into the mechanisms and potential benefits of proteasome inhibition
Publisher Springer
Publication date November 11, 2010
Edition 2011th
Language English
Print length 188 pages
ISBN-10 3764389478
ISBN-13 978-3764389475
Item Weight 15.2 ounces (430.92 grams)
Dimensions 6.2 x 0.6 x 9.4 inches (15.7 x 1.5 x 23.9 cm)
Part of series Milestones in Drug Therapy

Who Should Buy?

Suitable For
  • Healthcare Professionals

    Oncologists and healthcare professionals seeking comprehensive information on Bortezomib and its efficacy for treating multiple myeloma.

  • Medical Students

    Students studying oncology or drug therapy will benefit from detailed insights into Bortezomib's role in treatment protocols.

  • Patients and Caregivers

    Individuals affected by multiple myeloma who want to understand treatment options and experiences with Bortezomib.

Not Suitable For
  • General Public

    Individuals not involved in healthcare may find the technical content challenging and less relevant for general health understanding.

  • Alternative Medicine Advocates

    Those preferring non-pharmaceutical treatments may not align with the clinical focus and data presented in this book.

  • Casual Readers

    Readers seeking light reading or casual insights may find the material overly technical and dense for their interests.

Product Description

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition

Have any Query? Chat with us

Customer Questions & Answers

  • Question: What is Bortezomib and how does it work in treating Multiple Myeloma?

    Answer: Bortezomib is a proteasome inhibitor used as a chemotherapy drug in the treatment of Multiple Myeloma. It works by blocking the proteasome's function, leading to the accumulation of proteins that promote apoptosis, or programmed cell death, in cancer cells. This helps to hinder the growth of malignant plasma cells. In practice, patients may experience a reduction in tumor size and improvement in blood cell counts, making Bortezomib a pivotal part of combination therapies.
  • Question: What are the side effects of Bortezomib?

    Answer: Common side effects of Bortezomib can include nausea, fatigue, nerve damage, and low blood cell counts. Understanding these potential effects allows patients and caregivers to be proactive in managing symptoms and coordinating care. For instance, if a patient experiences severe fatigue, adjustments to their daily schedule and lifestyle might be warranted to ensure they maintain a good quality of life during treatment.
  • Question: How is Bortezomib administered to patients?

    Answer: Bortezomib can be administered via injection either subcutaneously or intravenously. The route and method depend on the specific treatment plan and the doctor's guidance. Patients might find subcutaneous injections more convenient as they can be less painful and simpler, helping to enhance compliance and ensuring the effectiveness of the therapy.
  • Question: What is the significance of the 2011 edition in drug therapy milestones for Bortezomib?

    Answer: The 2011 edition highlights pivotal studies and advancements in the use of Bortezomib over the years. It showcases critical milestones, including its approval and combination with other therapies, which have shaped current treatment protocols. This edition serves not just as a historical reference but also provides insights for clinicians in optimizing treatment strategies for more effective outcomes.
  • Question: Can Bortezomib be used in combination with other treatments?

    Answer: Yes, Bortezomib is often used in combination with other drugs such as dexamethasone and lenalidomide to enhance its effectiveness. This multi-drug approach is crucial as it attacks cancer cells from various angles, potentially leading to better remission rates. Combining therapies allows for more tailored treatment plans based on individual responses, expanding options for patients facing Multiple Myeloma.
  • Question: What should I know about monitoring while on Bortezomib therapy?

    Answer: Monitoring is essential during Bortezomib therapy due to its effects on blood counts and nerve health. Regular blood tests will help track changes and guide necessary adjustments in treatment. Additionally, patients should be vigilant for any new or worsening symptoms, enabling prompt medical response and management which is crucial for ensuring safe and effective treatment.
  • Question: What lifestyle changes may support patients undergoing Bortezomib treatment?

    Answer: Patients are encouraged to maintain a balanced diet, stay hydrated, and engage in light physical activity as tolerated, all of which contribute to overall health during treatment. Stress management practices such as mindfulness and yoga can also be beneficial. These lifestyle choices help bolster the body’s response to treatment and enhance the overall well-being of individuals fighting Multiple Myeloma.
  • Question: Is there a specific diet recommended for patients on Bortezomib?

    Answer: While there isn't a one-size-fits-all diet, a balanced intake rich in fruits, vegetables, lean proteins, and whole grains is generally recommended. Adequate nutrition can support immune function and help manage side effects such as nausea. For instance, consuming small, frequent meals can alleviate gastrointestinal discomfort, making it a practical strategy for those undergoing therapy.
  • Question: Are there any support resources for patients receiving Bortezomib?

    Answer: Several organizations provide support for patients undergoing Multiple Myeloma treatment with resources such as educational materials, counseling, and community support groups. Connecting with such resources can offer emotional support and useful information, aiding patients in navigating their journey through treatment more effectively.
  • Question: Where can I buy Bortezomib in the Treatment of Multiple Myeloma Milestones in Drug Therapy 2011th Edition?

    Answer: You can purchase the 2011th Edition of Bortezomib in the Treatment of Multiple Myeloma Milestones in Drug Therapy through Ubuy. Ubuy offers a user-friendly platform where you can find this specific edition, ensuring that you receive a reliable source for your medical literature needs, ultimately aiding in informed decisions about treatment.

Cell Biology Editorial Review

No editorial reviews found

Customer Reviews & Ratings

5.0
1 customers ratings
  • 5 Star
    100%
  • 4 Star
    0%
  • 3 Star
    0%
  • 2 Star
    0%
  • 1 Star
    0%

Review this product

Share your thoughts with other customers

Pros

  • Effective treatment option
  • Improves patient outcomes
  • Wide range of research support
  • Well-tolerated by many patients
  • Comprehensive information provided

Cons

  • Some may experience mild side effects.

Product Price History

Important information

  • Limitations : For products shipped internationally, please note that any manufacturer warranty may not be valid; manufacturer service options may not be available; product manuals, instructions, and safety warnings may not be in destination country languages; the products (and accompanying materials) may not be designed in accordance with destination country standards, specifications, and labeling requirements; and the products may not conform to destination country voltage and other electrical standards (requiring use of an adapter or converter if appropriate). The recipient is responsible for assuring that the product can be lawfully imported to the destination country. When ordering from Ubuy or its affiliates, the recipient is the importer of record and must comply with all laws and regulations of the destination country.
  • Not all the products listed on Ubuy are for sale, as Ubuy is a global search engine. Products are subject to export/trade regulations.

ETB 18160

Order now and get it around Thursday, July 16

QTY:

Secured transactionsecured transaction

Ubuy works hard to protect your security and privacy. Our advanced payment security system ensures confidentiality by encrypting your information during transmission using AES (Advanced Encryption Standards) and SSL (Secure Socket Layer) protocols. Your payment details are 100% secure as we do not share your payment details with third party sellers.

Our Top Logistics Partners
  • fedex
  • dhl
Fastest cross-border delivery

Features & Benefits

  • Bortezomib is a promising anticancer drug targeting the proteasome.
  • Induces cell stress and apoptosis in cancer cells.
  • Prevents degradation of pro-apoptotic factors, activating programmed cell death.
  • Valuable source of information for researchers and clinicians in oncology and pharmacology.
  • Suitable for those working in academia or the pharmaceutical industry.